Albertsons Q2 identical sales -0.8%; adj EPS $0.36 vs $0.44; FY2026 outlook withdrawn

Albertsons Companies, Inc.

Net sales $18.89B, down 0.1% YoY; identical sales fell 0.8%, digital sales rose 11%, pharmacy grew despite IRA headwinds.
Net income $51.5M ($0.11/sh) vs $168.5M ($0.30/sh); adjusted EPS $0.36 vs $0.44; adjusted EBITDA $784M vs $848M.
Withdraws FY2026 outlook; refreshed turnaround plan and short/long-term financial framework due with Q4 earnings; investor day Spring 2027.
Comprehensive business review covers customer strategy, cost structure, operating model, banners, assets and capital allocation; ACI Edge cut 11 divisions to four regions.
Declares $0.17/sh quarterly dividend payable Nov 6, 2026 (record Oct 23); YTD capex $899.6M funded 38 remodels and 7 new stores.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.